NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences
NeuroPace (Nasdaq: NPCE), a medical device company focused on epilepsy treatment, has announced its participation in two upcoming healthcare investor conferences in September. The company will:
- Host one-on-one meetings with investors at the Lake Street Big8 Best Ideas Growth Conference on September 12th in New York
- Present at the Cantor Global Healthcare Conference from September 17th-19th in New York, featuring a fireside chat with CEO Joel Becker and CFO Rebecca Kuhn on September 18th at 11:30am ET
The fireside chat will be available via live webcast and a replay will be accessible on NeuroPace's Investor website. These conferences provide opportunities for NeuroPace to engage with investors and showcase its innovations in epilepsy treatment.
NeuroPace (Nasdaq: NPCE), un'azienda di dispositivi medici focalizzata sul trattamento dell'epilessia, ha annunciato la sua partecipazione a due prossimi conferenze per investitori nel settore sanitario a settembre. L'azienda:
- Organizzerà incontri uno-a-uno con investitori alla Lake Street Big8 Best Ideas Growth Conference il 12 settembre a New York
- Presenterà alla Cantor Global Healthcare Conference dal 17 al 19 settembre a New York, con un incontro informale tra il CEO Joel Becker e il CFO Rebecca Kuhn il 18 settembre alle 11:30 ET
L'incontro informale sarà disponibile tramite webcast dal vivo e una replica sarà accessibile sul sito web per investitori di NeuroPace. Queste conferenze offrono opportunità a NeuroPace di interagire con gli investitori e mostrare le sue innovazioni nel trattamento dell'epilessia.
NeuroPace (Nasdaq: NPCE), una empresa de dispositivos médicos enfocada en el tratamiento de la epilepsia, ha anunciado su participación en dos conferencias de inversionistas en el sector de la salud que se llevarán a cabo en septiembre. La empresa:
- Realizará reuniones uno a uno con inversores en la Lake Street Big8 Best Ideas Growth Conference el 12 de septiembre en Nueva York
- Presentará en la Cantor Global Healthcare Conference del 17 al 19 de septiembre en Nueva York, con una charla informal con el CEO Joel Becker y la CFO Rebecca Kuhn el 18 de septiembre a las 11:30 am ET
La charla informal estará disponible a través de un webcast en vivo y una repetición estará accesible en el sitio web para inversionistas de NeuroPace. Estas conferencias ofrecen oportunidades para que NeuroPace interactúe con inversores y muestre sus innovaciones en el tratamiento de la epilepsia.
NeuroPace (Nasdaq: NPCE), 간질 치료에 중점을 둔 의료 기기 회사가 9월에 예정된 두 차례의 헬스케어 투자자 회의에 참여한다고 발표했습니다. 회사는:
- 9월 12일 뉴욕에서 열리는 Lake Street Big8 Best Ideas Growth Conference에서 투자자들과 1:1 미팅을 개최합니다.
- 9월 17일부터 19일까지 뉴욕에서 열리는 Cantor Global Healthcare Conference에 참석하여 CEO Joel Becker와 CFO Rebecca Kuhn이 9월 18일 오전 11시 30분 ET에 진행하는 대담을 포함할 것입니다.
대담은 라이브 웹캐스트를 통해 중계되며, NeuroPace의 투자자 웹사이트에서 재생이 가능합니다. 이러한 회의는 NeuroPace가 투자자와 소통하고 간질 치료의 혁신을 선보일 수 있는 기회를 제공합니다.
NeuroPace (Nasdaq: NPCE), une entreprise de dispositifs médicaux axée sur le traitement de l'épilepsie, a annoncé sa participation à deux conférences pour investisseurs dans le secteur de la santé prévues en septembre. L'entreprise va :
- Organiser des réunions en tête-à-tête avec des investisseurs lors de la Lake Street Big8 Best Ideas Growth Conference le 12 septembre à New York
- Présenter à la Cantor Global Healthcare Conference du 17 au 19 septembre à New York, avec une discussion informelle entre le PDG Joel Becker et la CFO Rebecca Kuhn le 18 septembre à 11h30 ET
La discussion informelle sera disponible via un webinaire en direct et une rediffusion sera accessible sur le site Web des investisseurs de NeuroPace. Ces conférences offrent à NeuroPace des opportunités d'interagir avec des investisseurs et de présenter ses innovations dans le traitement de l'épilepsie.
NeuroPace (Nasdaq: NPCE), ein medizinisches Geräteunternehmen, das sich auf die Behandlung von Epilepsie konzentriert, hat seine Teilnahme an zwei kommenden Investmentkonferenzen im Gesundheitswesen im September bekannt gegeben. Das Unternehmen wird:
- Einzelgespräche mit Investoren auf der Lake Street Big8 Best Ideas Growth Conference am 12. September in New York ausrichten
- Vom 17. bis 19. September auf der Cantor Global Healthcare Conference in New York präsentieren, einschließlich eines Fireside Chats mit CEO Joel Becker und CFO Rebecca Kuhn am 18. September um 11:30 Uhr ET
Der Fireside Chat wird über einen Live-Webcast verfügbar sein, und eine Wiederholung wird auf der Investorenseite von NeuroPace zugänglich sein. Diese Konferenzen bieten NeuroPace die Möglichkeit, mit Investoren in Kontakt zu treten und seine Innovationen in der Epilepsiebehandlung zu präsentieren.
- None.
- None.
MOUNTAIN VIEW, Calif., Aug. 27, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will participate in the following two healthcare investor conferences in September.
- Lake Street Big8 Best Ideas Growth Conference - NeuroPace management will host one-on-one meetings with investors at the Lake Street Big8 Best Ideas Growth Conference on Thursday, September 12th in New York.
- Cantor Global Healthcare Conference - NeuroPace will present at the Cantor Global Healthcare Conference, which takes place September 17th-19th, in New York. Joel Becker, Chief Executive Officer, and Rebecca Kuhn, Chief Financial Officer, will participate in a fireside chat discussion on Wednesday, September 18th at 11:30am ET, and host one-on-one meetings with investors during the conference. The fireside chat will be accessible via a live webcast here and a replay will be available on the Events section of NeuroPace’s Investor website at https://investors.neuropace.com/news-and-events/events.
About NeuroPace, Inc.
Based in Mountain View, Calif., NeuroPace is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.
Investor Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
jfeffer@lifesciadvisors.com
FAQ
What investor conferences will NeuroPace (NPCE) attend in September 2024?
When is NeuroPace's (NPCE) fireside chat at the Cantor Global Healthcare Conference?
Who will represent NeuroPace (NPCE) at the Cantor Global Healthcare Conference?
How can investors access NeuroPace's (NPCE) fireside chat at the Cantor conference?
